05:14 PM EDT, 03/20/2026 (MT Newswires) -- Claire Mazumdar, Director, Chief Executive Officer, on March 18, 2026, sold 15,000 shares in Bicara Therapeutics ( BCAX ) for $282,366. Following the Form 4 filing with the SEC, Mazumdar has control over a total of 339,392 common shares of the company, with 339,392 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2023658/000162828026020236/xslF345X05/wk-form4_1774040575.xml